Prescient Therapeutics LimitedASX: PTX

Prescient Therapeutics: Replacement Entitlement Offer Prospectus

· Issued by Prescient Therapeutics Limited

Filed with ASX · · 44 pages · English

Non-renounceable pro rata entitlement offer of 1 New Share for every 3 Existing Shares (and 1 New Option for every 2 New Shares issued) at an offer price of $0.09 per New Share to raise approximately $3.4 million (before the exercise of any New Options) Last date for acceptance and payment: 5.00pm (Sydney time) on 21 June 2016. If you are an Eligible Shareholder, this is an important document that

Prescient Therapeutics Limited on 6ix

Earlier from Prescient Therapeutics

Later from Prescient Therapeutics

All Prescient Therapeutics news releases